Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in City of West: The Complete Guide for Women, Families, and Survivors

For the women and families in City of West who are navigating the aftermath of a failed breast reconstruction or a complicated aesthetic procedure, the road to recovery often feels paved with more questions than answers. You may have undergone a mastectomy and reconstruction at a regional medical hub like Baylor Scott & White in Waco or Temple, or perhaps a cosmetic revision at a high-volume center serving McLennan County. Regardless of where the surgery took place, the discovery that a medical device implanted in your body—a piece of surgical mesh, a sheet of acellular dermal matrix (ADM), or a bioabsorbable scaffold—may be the source of your pain or a new cancer diagnosis is life-altering. We recognize that for a community like City of West, which has a deeply rooted history of resilience and a unique understanding of how corporate and industrial safety failures can impact families, the search for accountability is personal.

We have built this guide as a definitive resource for City of West patients, their families, and the survivors of those lost to medical device complications. At the Manginello Law Firm, PLLC, operating under the Attorney911 brand, we don’t just handle cases; we examine the regulatory failures and scientific data that lead to patient harm. Managing Partner Ralph Manginello brings twenty-seven years of continuous practice and a rigorous focus on institutional liability to every consultation. Along with Associate Attorney Lupe Peña, who provides fluent Spanish-language representation for the many Spanish-dominant families across Central Texas and the McLennan County area, we are dedicated to ensuring that women in City of West are not forced to carry the burden of a manufacturer’s failure alone. Whether you are facing a diagnosis of BIA-ALCL, struggling with chronic infection, or dealing with the loss of a reconstruction, we provide the technical command of federal device law and the compassionate authority you deserve.

Understanding the Devices: Surgical Mesh, ADM, and Bioabsorbable Scaffolds

Many women in City of West may be surprised to learn that the “internal bra” or the “support matrix” their surgeon described is actually a Class II medical device cleared for general soft-tissue reinforcement, but never specifically approved by the FDA for breast surgery. To understand your legal options, you must first understand what was placed in your body. Acellular Dermal Matrix (ADM) is a biologic material, often derived from human cadaver skin or animal tissue (porcine or bovine), that has been processed to remove all cells while leaving the structural collagen matrix intact. In City of West area hospitals, ADMs like AlloDerm or Strattice are frequently used to create a pocket for a breast implant or tissue expander, providing an extra layer of support.

Bioabsorbable scaffolds, such as GalaFLEX or Phasix, represent a different category. These are synthetic products made from polymers like poly-4-hydroxybutyrate (P4HB). They are designed to provide temporary support and then slowly resorb into the body over 12 to 24 months, theoretically leaving behind a stronger layer of natural tissue. However, as many patients in McLennan County have discovered, these scaffolds sometimes fail to resorb on schedule, leading to palpable edges, chronic inflammation, and “bottoming out” of the implant. Purely synthetic surgical mesh, often made of polypropylene, is also used off-label in some breast procedures, though it was never designed for the delicate environment of breast tissue. When these devices fail, the consequences for City of West women range from painful revision surgeries to life-threatening sepsis and rare forms of cancer.

The Brand Universe: Products Used in City of West Reconstruction and Revision

When we investigate a case for a client in City of West, the first step is often identifying the specific brand of matrix or scaffold used. Because hospitals are required to retain device implant stickers, we can trace the manufacturer back to the source. The following products are currently central to our litigation focus:

Acellular Dermal Matrix (ADM) Brands

• AlloDerm and AlloDerm RTU: Manufactured by Allergan (now AbbVie), this was the first major ADM on the market and is widely used across Texas.
• Strattice Reconstructive Tissue Matrix: A porcine-derived matrix also from the Allergan/AbbVie/LifeCell lineage.
• FlexHD and FlexHD Pliable: Manufactured by MTF Biologics and distributed by Ethicon. This brand was specifically named by the FDA in 2021 for having significantly higher complication rates.
• AlloMax: A C.R. Bard/Becton Dickinson (BD) product also flagged by the FDA for elevated explantation and infection risks.
• SurgiMend: A bovine-derived matrix from Integra LifeSciences known for higher rates of capsular contracture.

Bioabsorbable and Resorbable Scaffold Brands

• GalaFLEX (Scaffold, 3D, 3DR, Lite): These P4HB products from Galatea Surgical and Becton Dickinson are currently the subject of intense scrutiny following whistleblower allegations and FDA labeling updates.
• Phasix Mesh: Another BD product made of P4HB, frequently used for abdominal wall reinforcement but used off-label in breast surgery.
• DuraSorb: A monofilament mesh made of polydioxanone (PDO), currently being studied in clinical trials but already used in many McLennan County reconstruction procedures.

For a woman in City of West, knowing which of these was used is the key to identifying the correct defendant. If your surgeon used FlexHD or AlloMax, for instance, we look to the specific 2021 FDA safety communication as a cornerstone of your failure-to-warn claim. If your procedure involved GalaFLEX, we examine the manufacturer’s marketing history and the FDA’s 2023 directive that explicitly stated the safety of these products in breast surgery has not been determined.

The FDA Regulatory Failure: 510(k) and “Predicate Creep”

The question we hear most often in City of West is: “How was this allowed to happen?” The answer lies in the FDA’s 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807, a manufacturer can bring a device to market without conducting new clinical trials if they can prove it is “substantially equivalent” to a “predicate device” that is already on the market. This is not the same as FDA “approval.” In fact, as Ralph Manginello and our team often explain, 510(k) clearance is a comparative shortcut.

In the case of products like GalaFLEX, the manufacturer claimed equivalence to a surgical suture. This is what we call “predicate creep”—the process by which a device enters the market by claiming to be like an earlier device, which was like an even earlier device, until the final product (a large mesh scaffold for breast support) is being cleared based on technology for a single stitch. This regulatory maneuver allowed these devices to enter City of West operating rooms without being specifically tested for safety in breast tissue. As we often tell our clients, the Supreme Court in Medtronic v. Lohr (1996) made it clear that 510(k) clearance does not preempt state-law injury claims. This means you have the right to hold the manufacturer accountable in a City of West or McLennan County court, even if they had FDA clearance to market the device for “general soft tissue” use.

The Whistleblower: Dr. Hooman Noorchashm and Becton Dickinson

One of the most critical developments for City of West patients is the whistleblower record of Dr. Hooman Noorchashm. A cardiothoracic surgeon and professor, Dr. Noorchashm was hired as a Medical Director by Becton Dickinson (BD) in 2022. He was terminated after only six months for raising safety objections regarding the marketing of GalaFLEX. His public record and subsequent litigation allege that BD withheld data concerning breast cancer recurrences in its own clinical trials and failed to properly report adverse events to the FDA’s MAUDE database.

For a breast cancer survivor in City of West, these allegations are chilling. The theory we pursue is that manufacturers were more concerned with the lucrative “internal bra” market than with the long-term safety of the women receiving these products. When a manufacturer conceals safety data or promotes a device for an unapproved use like breast reconstruction without revealing the risks, they have violated the trust of the surgeons and the patients alike. Our firm’s experience with high-profile institutional litigation—such as our lead role in the Bermudez v. Pi Kappa Phi case where we are seeking $10,000,000 against thirteen defendants—means we have the structural capacity to take on global device manufacturers like Becton Dickinson.

Complications and Clinical Reality in City of West

The physical toll of defective mesh or ADM is often categorized into medical terms that can feel detached from the reality of the pain. We believe women in City of West deserve to know the technical pathology of what is happening to their bodies.

BIA-ALCL: Breast Implant-Associated Anaplastic Large Cell Lymphoma

This is not breast cancer; it is a rare T-cell non-Hodgkin lymphoma that develops in the scar tissue around an implant. It is highly associated with textured surfaces, such as those in the recalled Allergan BIOCELL implants. If you are a City of West patient with BIOCELL devices, pathologist reports showing CD30-positive and ALK-negative cells are a critical evidentiary marker. The July 2019 recall was a watershed moment, but many women are only now discovering their symptoms years later.

BIA-SCC: Breast Implant-Associated Squamous Cell Carcinoma

Newer medical literature and a September 2022 FDA safety communication have identified BIA-SCC as an emerging threat. This epithelial tumor can develop in the capsule of both smooth and textured implants. For a woman in McLennan County who has had her implants for 10, 20, or even 40 years, sudden swelling or a new mass must be treated with immediate clinical suspicion.

Red Breast Syndrome (RBS)

Unique to ADM products, this is a noninfectious, sterile inflammation where the breast skin turns bright red. Research, including the foundational 2019 studies by Nguyen et al., suggests this is caused by bacterial endotoxins (LPS) that survive the sterilization process. If you were told you had an “infection” that didn’t respond to antibiotics, you likely had Red Breast Syndrome caused by a defective ADM.

Mesh Extrusion and Reconstruction Failure

In many City of West cases, the mesh or scaffold fails to integrate, eventually eroding through the skin (extrusion). This often leads to a “total reconstruction failure,” which is not just an aesthetic loss but a profound psychological trauma. When we represent a client who has lost her reconstruction, we seek damages for the five to eight additional surgeries she may need to achieve a “flat closure” or to attempted salvage with autologous tissue flaps (like the DIEP or TRAM flap).

Who is Liable? The Path to Accountability in McLennan County

Navigating a lawsuit in City of West requires understanding which legal doctrines apply. Most generalist personal injury firms might only see a medical malpractice claim against the surgeon. We look deeper.

1. The Manufacturer (Strict Product Liability): Under Texas law, we can hold the manufacturer strictly liable for a design defect, a manufacturing defect, or a failure to warn. If the manufacturer knew GalaFLEX was being used off-label in breast surgery but failed to warn surgeons about the risk of resorption failure, they are the primary target of the litigation.
2. The “Perez v. Wyeth” Exception to Learned Intermediary: Manufacturers often argue they only had to warn the surgeon (the “learned intermediary”). However, in jurisdictions that follow the reasoning of Perez v. Wyeth (1999), if the manufacturer marketed the device directly to consumers or engaged in aggressive off-label promotion that bypassed the surgeon’s independent judgment, that defense fails.
3. Institutional Liability and Negligent Credentialing: In some cases, a hospital or surgical center in the Waco or City of West area may be liable if they continued to stock and use a device like FlexHD after its high failure rates were common knowledge in the medical community.

Our associate attorney, Lupe Peña, brings a unique perspective to this process. Having a background in insurance defense, Lupe knows exactly how high-stakes corporate counsel will try to blame the patient’s “pre-existing conditions” or “lifestyle” for the device failure. We use that insider knowledge to stay three steps ahead of their defense strategy.

Statutes of Limitations: Why the Discovery Rule Matters in City of West

In Texas, the general statute of limitations for personal injury and product liability is two years. However, for a woman in City of West who had her surgery five years ago and only developed BIA-ALCL or felt her GalaFLEX scaffold migrate last month, the “discovery rule” is your lifeline. Under Texas law, the clock often doesn’t start ticking until you knew, or reasonably should have known, that you were injured and that the injury was caused by a specific device.

The FDA’s November 2023 letter was a significant “discovery” event for many women. If you are reading this from City of West and are worried that it is too late because your original surgery was years ago, don’t assume you are barred. We evaluate the timeline of your symptoms, your pathology reports, and the manufacturer’s recall history to determine your exact filing deadline. Because these cases involve complex federal preemption questions (the Riegel and Buckman doctrines), having a firm that understands the Southern District of Texas and Western District of Texas federal dockets is essential.

Evidence Checklist for City of West Patients

If you suspect your breast mesh, ADM, or scaffold is failing, we recommend you take the following steps immediately to protect your future claim. These are the same steps we discuss during our free consultations at 1-888-ATTY-911:

• Secure Your Operative Reports: Your surgeon’s office or the hospital in McLennan County where your surgery occurred must provide these. The operative report will name the exact brand and size of the matrix or scaffold used.
• Locate the “UDI” Stickers: Hospitals are required to keep the “Unique Device Identifier” stickers from the product packaging in your permanent file. These are the gold standard for evidence.
• Request Your Pathology Slides: If you had a revision or a “washout” procedure, the tissue removed was sent to a lab. We may need that tissue or the slides to test for CD30+ cells or for evidence of an immunological reaction to the mesh.
• Document Everything: Take photographs of redness, swelling, or extrusion. Keep a journal of your pain levels and any systemic symptoms (fatigue, joint pain, hair loss) which may be associated with Breast Implant Illness (BII).
• Hablamos Español: If Spanish is the language you speak at home, please know that Lupe Peña conducts our consultations directly in Spanish. Your story won’t be lost in translation.

Frequently Asked Questions for City of West Families

Is surgical mesh actually banned in breast surgery?
No, but it is not “approved.” The FDA’s position, reiterated in November 2023, is that the safety and effectiveness of mesh in breast surgery have not been determined. It is being used “off-label,” which means the manufacturer bears the responsibility for the risks they haven’t disclosed.

What if I can’t afford a lawyer?
At the Manginello Law Firm, we work on a contingency fee basis. This means families in City of West pay us nothing upfront. We only get paid if we recover compensation for you. We assume all the risk of the litigation.

Will I have to travel to New Jersey for the Allergan MDL?
In most cases, no. While the federal Allergan BIOCELL litigation is centralized as MDL 2921 in the District of New Jersey before Judge Brian R. Martinotti, the initial stages of your case are handled by us from our Texas offices. We deal with the New Jersey court so you can focus on your recovery in City of West.

How much is a breast mesh case worth in Texas?
Every case is unique. However, comparable mesh settlements—like the $1 billion Bard hernia mesh resolution in 2024 or the $8 billion transvaginal mesh aggregate—show that when companies fail to warn about known risks, the damages for medical costs, lost wages, and permanent disfigurement can be substantial.

What if my surgeon told me the mesh was “dissolvable”?
Many P4HB scaffolds like GalaFLEX are marketed as bioabsorbable. If yours did not dissolve or if it caused an intensive reaction before it could resorb, you may have a claim based on a design defect or a manufacturing defect.

Why City of West Survivors Choose Attorney911

The Manginello Law Firm is not a “settlement mill.” We are trial attorneys who are currently prosecuting complex, multi-defendant cases like the Bermudez fraternity hazing litigation, where we are holding powerful institutions accountable for systemic failures. Ralph Manginello’s Avvo “Excellent” rating of 8.2 and his 5.0-star client review score are a reflection of his twenty-seven years of building trust with Texas families. We are members of the Pro Bono College of the State Bar of Texas, requiring over 75 hours of service annually, because we believe the law is a tool for service.

Whether you are a breast cancer survivor who just want to know if your ADM is safe, or you are a daughter seeking justice for a mother who died from sepsis following a reconstruction failure, we are here for you. City of West is a community that looks out for its own, and we are proud to be the firm that looks out for City of West.

If you are ready to talk, we are ready to listen. There is no cost for your first talk with us, and no obligation to move forward unless you are ready. You can reach us 24/7 at 1-888-ATTY-911 (1-888-288-9911). When you call, ask to speak with Ralph Manginello or Lupe Peña.

Si prefiere hablar en español, la abogada Lupe Peña está disponible para una consulta completa sin necesidad de intérpretes. Estamos aquí para proteger sus derechos y asegurar que su familia reciba la justicia que merece.

Confidential Resources and Navigation for City of West Patients

• National Cancer Institute (NCI): To find the nearest Comprehensive Cancer Center to City of West, visit cancercenters.cancer.gov.
• The PROFILE Registry: If you have been diagnosed with BIA-ALCL, ensure your case is recorded at ThePSF.org/PROFILE.
• Susan G. Komen Breast Care Helpline: For immediate support and patient navigation, call 1-877-465-6636 (Spanish available).
• FORCE: For women with BRCA1 or BRCA2 mutations in the City of West area, visit facingourrisk.org.

Your health is the most important thing. When you are ready to address the legal side of what happened to you, the team at Attorney911 will be standing by. Call us at 1-888-288-9911 for a free, confidential case evaluation.